Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ikram Mezghiche, Hanane Yahia-Cherbal, Lars Rogge & Elisabetta Bianchi. (2021) Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers. Expert Review of Clinical Immunology 17:4, pages 331-354.
Read now
Read now
Kenta Kaneshiro, Kohsuke Yoshida, Kanta Morii, Yuto Oketani, Koto Uchida, Arisa Yaekura, Ikumi Okumura, Teppei Hashimoto, Yoshiko Kawasaki, Nao Shibanuma, Yoshitada Sakai & Akira Hashiramoto. (2020) Expressions of circadian clock genes represent disease activities of RA patients treated with biological DMARDs. Modern Rheumatology 30:2, pages 293-300.
Read now
Read now
Shintaro Hirata, Wanying Li, Satoshi Kubo, Shunsuke Fukuyo, Yasushi Mizuno, Kentaro Hanami, Norifumi Sawamukai, Kunihiro Yamaoka, Kazuyoshi Saito, Nadine A. Defranoux & Yoshiya Tanaka. (2016) Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice. Modern Rheumatology 26:6, pages 850-856.
Read now
Read now
Shintaro Hirata, Nadine Defranoux, Kentaro Hanami, Kunihiro Yamaoka & Yoshiya Tanaka. (2015) A multi-biomarker disease activity score for monitoring rheumatoid arthritis. Current Biomarker Findings 5, pages 69-78.
Read now
Read now
Hanna L Gul, Joana F Ferreira & Paul Emery. (2015) Remission in rheumatoid arthritis: is it all the same?. Expert Review of Clinical Pharmacology 8:5, pages 575-586.
Read now
Read now
Articles from other publishers (10)
Fanni A Meznerics, Lajos V Kemény, Emese Gunther, Eszter Bakó, Fanni Dembrovszky, Bence Szabó, Anna Ascsillán, Elmar Lutz, Dezsö Csupor, Péter Hegyi, András Bánvölgyi & György Nagy. (2023) Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis. Rheumatology 62:6, pages 2048-2059.
Crossref
Crossref
Carlos Melus, Brenden Rossin, Mary Ann Aure & Michael Mahler. 2021. Precision Medicine and Artificial Intelligence. Precision Medicine and Artificial Intelligence
65
96
.
Tate M. Johnson, Kyle A. Register, Cynthia M. Schmidt, James R. O'Dell, Ted R. Mikuls, Kaleb Michaud & Bryant R. England. (2019) Correlation of the Multi‐Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta‐Analysis. Arthritis Care & Research 71:11, pages 1459-1472.
Crossref
Crossref
Nadia M. T. Roodenrijs, Maria J. H. de Hair, Gill Wheater, Mohsen Elshahaly, Janneke Tekstra, Y. K. Onno Teng, Floris P. J. G. Lafeber, Ching Chang Hwang, Xinyu Liu, Eric H. Sasso & Jacob M. van Laar. (2018) The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Christoph Kessel, Angela McArdle, Emely Verweyen, Toni Weinhage, Helmut Wittkowski, Stephen R. Pennington & Dirk Foell. (2018) Proteomics in Chronic Arthritis—Will We Finally Have Useful Biomarkers?. Current Rheumatology Reports 20:9.
Crossref
Crossref
Gary M Oderda, Grant D Lawless, Grace C Wright, Samuel R Nussbaum, Renwyck Elder, Kibum Kim & Diana I Brixner. (2018) The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs. Personalized Medicine 15:4, pages 291-301.
Crossref
Crossref
Marjan Ghiti Moghadam, Femke B. G. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Annemarie M. Schilder, Henk Visser, Eric H. Sasso, David Chernoff, Willem F. Lems, Dirk-Jan van Schaardenburg, Robert Landewe, Hein J. Bernelot Moens, Timothy R. D. J. Radstake, Piet L. C. M. van Riel, Mart A. F. J. van de Laar & Tim L. Jansen. (2018) Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment. PLOS ONE 13:5, pages e0192425.
Crossref
Crossref
Gablu Kilcher, Noemi Hummel, Eva M Didden, Matthias Egger & Stephan Reichenbach. (2018) Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries. Rheumatology 57:2, pages 354-369.
Crossref
Crossref
Roy Fleischmann, Sean E. Connolly, Michael A. Maldonado & Michael Schiff. (2016) Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab. Arthritis & Rheumatology 68:9, pages 2083-2089.
Crossref
Crossref
B. Stuhlmüller, K. Skriner & T. Häupl. (2015) Biomarker zur Prognose des Ansprechens auf eine Anti-TNF-Therapie bei der rheumatoiden ArthritisBiomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis. Zeitschrift für Rheumatologie 74:9, pages 812-818.
Crossref
Crossref